Molecular Mechanisms in Chronic Venous Insufficiency

Annals of Vascular Surgery

Volumn 21, Issue 3, 2007, Pages 260-266

  Bergan, John ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL SURFACE; CHRONIC VEIN INSUFFICIENCY; ENDOTHELIUM CELL; HYPERTENSION; MOLECULAR MECHANICS; PRIORITY JOURNAL; SHEAR STRESS; ULCER; VARICOSIS; VEIN VALVE; VEIN WALL;

ANIMALS; BLOOD PRESSURE; CHRONIC DISEASE; ENDOTHELIUM, VASCULAR; EXTREMITIES; HUMANS; HYPERTENSION; REGIONAL BLOOD FLOW; SHEAR STRENGTH; VARICOSE ULCER; VENOUS INSUFFICIENCY;

EID: 34247590871     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2007.03.011     Document Type: Article

References (59)

1. Labropoulos N. Hemodynamic changes according to the CEAP classification. Phlebolymphology 40 (2003) 130-136
2. Moyses C., Cederholm-Williams S.A., and Michel C.C. Haemoconcentration and accumulation of white cells in the feet during venous stasis. Int J Microcirc Clin Exp 5 (1987) 311-320
3. Thomas P.R., Nash G.B., and Dormandy J.A. White cell accumulation in dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin. Br Med J 296 (1988) 1693-1695
4. Wilkinson L.S., Bunker C., Edwards J.C., Scurr J.H., and Coleridge Smith P.D. Leukocytes: their role in the etiopathogenesis of skin damage in venous disease. J Vasc Surg 17 (1993) 669-675
5. Pappas P.J., DeFouw D.O., Venezio L.M., et al. Morphometric assessment of the dermal microcirculation in patients with chronic venous insufficiency. J Vasc Surg 26 (1997) 784-785
6. Lalka S.G., Unthank J.L., and Nixon J.C. Elevated cutaneous leukocyte concentration in a rodent model of acute venous hypertension. J Surg Res 74 (1998) 59-63
7. Hahn T.L., Unthank J.L., and Lalka S.G. Increased hindlimb leukocyte concentration in a chronic rodent model of venous hypertension. J Surg Res 81 (1999) 38-41
8. Yong K., and Khwaja A. Leucocyte cellular adhesion molecules. Blood Rev 4 (1990) 211-225
9. Saharay M., Shields D.A., Porter J.B., Scurr J.H., and Coleridge Smith P.D. Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease. J Vasc Surg 25 (1997) 265-273
10. Saharay M., Shields D.A., Georgiannos S.N., Porter L.B., Scurr J.H., and Coleridge Smith P.D. Endothelial activation in patients with chronic venous disease. Eur J Vasc Endovasc Surg 15 (1998) 342-349
11. Shields D.A., Andaz S.K., Abeysinghe R.D., Porter J.B., Scurr J.H., and Coleridge Smith P.D. Plasma lactoferrin as a marker of white cell degranulation in venous disease. Phlebology 9 (1994) 55-58
12. Shields D.A., Andaz S.K., Sarin S., Scurr J.H., and Coleridge Smith P.D. Plasma elastase in venous disease. Br J Surg 81 (1994) 1496-1499
13. Ciuffetti G., Lombardini R., Pasqualini L., Vaudo G., and Lupattelli G. Circulating leucocyte adhesion molecules in chronic venous insufficiency. Vasa 28 (1999) 156-159
14. Vanscheidt W.Q., Kresse O., Hach-Wunderle V., et al. Leg ulcer patients: no decreased fibrinolytic response but white cell trapping after venous occlusion of the upper limb. Phlebology 7 (1992) 92-96
15. Takase S., Schmid-Schönbein G., and Bergan J.J. Leukocyte activation in patients with venous insufficiency. J Vasc Surg 30 (1999) 148-156
16. Burnand K.G., Whimster I., Clemenson G., Thomas M.L., and Browse N.L. The relationship between the number of capillaries in the skin of the venous ulcer-bearing area of the lower leg and the fall in vein pressure during exercise. Br J Surg 68 (1981) 297-300
17. Junger M., Hahn U., Bort S., Klyscz T., Hahn M., and Rassner G. Significance of cutaneous microangiopathy for the pathogenesis of dermatitis in venous congestion due to chronic venous insufficiency. Wien Med. Wochenschr 144 (1994) 206-210
18. Bates D.O., and Curry F.E. Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels. Am J Physiol 271 (1996) H2520-H2528
19. Shoab S.S., Scurr J.H., and Coleridge Smith P.D. Increased plasma endothelial growth factor among patients with chronic venous disease. J Vasc Surg 28 (1998) 535-540
20. Shoab S.S., Scurr J.H., and Coleridge Smith P.D. Plasma VEGF as a marker of therapy in patients with chronic venous disease treated with oral micronised flavonoid fraction-a pilot study. Eur J Endovasc Surg 18 (1999) 334-338
21. Pappas P.J., You R., Rameshwar P., et al. Dermal tissue fibrosis in patients with chronic venous insufficiency is associated with increased transforming growth factor β1 gene expression and protein production. J Vasc Surg 30 (1999) 1129-1145
22. Sansilvestri-Morel P., Rupin A., Jaisson S., Fabiani J.-N., Verbeuren T.J., and Vanhoutte P.M. Synthesis of collagen is dysregulated in cultured fibroblasts derived from skin of subjects with varicose veins as it is in venous smooth muscle cells. Circulation 106 (2002) 479-483
23. Peschen M., Grenz H., Grothe C., Schopf E., and Vanscheidt W. Patterns of epidermal growth factor receptor, basic fibroblast growth factor and transforming growth factor-3 expression in skin with chronic venous insufficiency. Eur J Dermatol 8 (1998) 334-338
24. Van Cleef J.F., Hugentobler J.P., Desvaux P., Griton P., and Cloarec M. Étude endoscopique des reflux valvulaires saphéniens. J Mal Vasc 17 Suppl. B (1992) 113-116
25. Sales C.M., Rosenthal D., Petrillo K.A., et al. The valvular apparatus in venous insufficiency: a problem of quantity?. Ann Vasc Surg 12 (1998) 153-155
26. Ono T., Bergan J.J., Schmid-Schönbein G.W., and Takase S. Monocyte infiltration into venous valves. J Vasc Surg 27 (1998) 158-166
27. Takase S., Bergan J.J., and Schmid-Schönbein G.W. Expression of adhesion molecules and cytokines on saphenous veins in chronic venous insufficiency. Ann Vasc Surg 14 (2000) 427-435
28. van Bemmelen S.P., Hoynck van Papendrecht A.A., Hodde K.C., and Klopper P.J. A study of valve incompetence that developed in an experimental model of venous hypertension. Arch Surg 121 (1986) 1048-1052
29. Takase S., Pascarella L., Bergan J.J., and Schmid-Schönbein G.W. Hypertension-induced venous valve remodeling. J Vasc Surg 39 (2004) 1329-1334
30. Takase S., Pascarella L., Lerond L., Bergan J.J., and Schmid-Schönbein G.W. Venous hypertension, inflammation and valve remodeling. Eur J Vasc Endovasc Surg 28 (2004) 484-493
31. Takase S., Lerond L., Bergan J.J., and Schmid-Schönbein G.W. The inflammatory reaction during venous hypertension in the rat. Microcirculation 7 (2000) 41-52
32. Takase S., Lerond L., Bergan J.J., and Schmid-Schönbein G.W. Enhancement of reperfusion injury by elevation of microvascular pressures. Am J Physiol 282 (2002) H1387-H1394
33. Traub O., and Berk B.C. Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol 18 (1998) 677-685
34. Yoshizumi M., Abe J., Tsuchiya K., Berk B.C., and Tamaki T. Stress and vascular responses: atheroprotective effect of laminar fluid shear stress in endothelial cells: possible role of mitogen-activated protein kinases. J Pharmacol Sci 91 (2003) 172-176
35. Weinbaum S., Zhang X., Han Y., Vink H., and Cowin S.C. Mechanotransduction and flow across the endothelial glycocalyx. Proc Natl Acad Sci USA 100 (2003) 7988-7995
36. Chen B.P.C., Li Y.-S., Zhao Y., et al. DNA microarray analysis of gene expression in endothelial cells in response to 24-h shear stress. Physiol Genomics 7 (2001) 55-63
37. Brooks A.R., Lelkes P.I., and Rubanyi G.M. Gene expression profiling of human aortic endothelial cells exposed to disturbed flow and steady laminar flow. Physiol Genomics 9 (2002) 27-41
38. Ohura N., Yamamoto K., Ichioka S., et al. Global analysis of shear stress-responsive genes in vascular endothelial cells. J Atheroscler Thromb 10 (2003) 304-313
39. Davies P.F., Remuzzi A., Gordon E.J., Dewey C.F., and Gimbrone M.A. Turbulent fluid shear stress induces vascular endothelial cell turnover in vitro. Proc Natl Acad Sci USA 83 (1986) 2114-2117
40. Berk B.C., Abe J.I., Min W., Surapisitchat J., and Yan C. Endothelial atheroprotective and anti-inflammatory mechanisms. Ann NY Acad Sci 947 (2001) 93-109
41. Hsiai T.K., Cho S.K., Reddy S., et al. Pulsatile flow regulates monocyte adhesion to oxidised lipid-induced endothelial cells. Arterioscler Thromb Vasc Biol 21 (2001) 1770-1776
42. Passerini A.G., Milsted A., and Rittgers S.E. Shear stress magnitude and directionality modulate growth factor gene expression in preconditioned vascular endothelial cells. J Vasc Surg 37 (2003) 182-190
43. Sorescu G.P., Sykes M., Weiss D., et al. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response. J Biol Chem 278 (2003) 31128-31135
44. Moazzam F., DeLano F.A., Zweifach B.W., and Schmid-Schönbein G.W. The leukocyte response to fluid stress. Proc Natl Acad Sci USA 94 (1997) 5338-5343
45. Fukuda S., and Schmid-Schönbein G.W. Regulation of CD18 expression on neutrophils in response to fluid shear stress. Proc Natl Acad Sci USA 100 (2003) 13152-13157
46. Fukuda S., Yasu T., Predescu D.N., and Schmid-Schönbein G.W. Mechanisms for regulation of fluid shear stress response in circulating leukocytes. Circ Res 86 (2000) e13-e18
47. Marschel P., and Schmid-Schönbein G.W. Control of fluid shear response in circulation leukocytes by integrins. Ann Biomed Eng 30 (2002) 333-343
48. Fukuda S., Mitsuoka H., and Schmid-Schönbein G.W. Leukocyte fluid shear response in the presence of glucocorticoid. J Leukoc Biol 75 (2004) 664-670
49. Florian J.A., Kosky J.R., Ainslie K., Pang Z., Dull R.O., and Tarbell J.M. Heparan sulfate proteoglycan is a mechanosensor on endothelial cells. Circ Res 93 (2003) e136-e142
50. Secomb T.W., Hsu R., and Pries A.R. Effect of the endothelial surface layer on transmission of fluid shear stress to endothelial cells. Biorheology 38 (2001) 143-150
51. Smith M.L., Long D.S., Damiano E.R., and Ley K. Near-wall μ-PIV reveals a hydrodynamically relevant endothelial surface layer in venules in vivo. Biophys J 85 (2003) 637-645
52. Zhao Y., Chein S., and Weinbaum S. Dynamic contact forces on leukocyte microvilli and their penetration of the endothelial glycocalyx. Biophys J 80 (2001) 1124-1140
53. Mulivor A.W., and Lipowsky H.H. Role of the glycocalyx in leukocyte-endothelial cell adhesion. Am J Physiol 283 (2002) H1282-H1291
54. Henry C.B., and Duling B.R. TNF-α increases entry of macomolecules into luminal endothelial cell glycocalyx. Am J Physiol 279 (2000) H2815-H2823
55. 2A receptor activation. Am J Physiol 284 (2003) H2360-H2367
56. Mulivor A.W., and Lipowsky H.H. Inflammation- and ischemia-induced shedding of venular glycocalyx. Am J Physiol 286 (2004) H1672-H1680
57. Secomb T.W., Konerding M.A., West C.A., Su M., Young A.J., and Mentzer S.J. Microangiectasias: structural regulators of lymphocyte transmigration. Proc Natl Acad Sci USA 100 (2003) 7231-7234
58. Coleridge Smith P.D., and Bergan J.J. Inflammation in venous disease. In: Schmid-Schönbein G.W., and Granger N. (Eds). Molecular Basis for Microcirculatory Disorders (2003), Springer-Verlag, Paris 489 Schmid-Schönbein GW, Granger N (Eds). 500
59. Traub O., and Berk B.C. Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol 18 (1998) 677 Schmid-Schönbein GW, Granger N (Eds). 685